Predictive Oncology
POAI
POAI
29 hedge funds and large institutions have $3.96M invested in Predictive Oncology in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% less ownership
Funds ownership: 0.31% → 0.31% (-0%)
Holders
29
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$66K | |
| 2 | +$54K | |
| 3 | +$25K | |
| 4 |
SC
Scotia Capital
Toronto,
Ontario, Canada
|
+$24K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$22.2K |
Top Sellers
| 1 | -$219K | |
| 2 | -$35K | |
| 3 | -$7.63K | |
| 4 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$3.88K |
| 5 |
FC
Fusion Capital
Mt. Pleasant,
South Carolina
|
-$224 |